Your browser doesn't support javascript.
loading
An Overview of Muscle Atrophy.
Ding, Shengguang; Dai, Qiying; Huang, Haitao; Xu, Yiming; Zhong, Chongjun.
Afiliação
  • Ding S; Department of Thoracic and Cardiovascular Surgery, The Second Affiliated Hospital of Nantong University, Nantong, China.
  • Dai Q; Metrowest Medical Center, Framingham, MA, USA.
  • Huang H; Department of Cardiology, First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Xu Y; Department of Thoracic and Cardiovascular Surgery, The Second Affiliated Hospital of Nantong University, Nantong, China.
  • Zhong C; Department of Thoracic and Cardiovascular Surgery, The Second Affiliated Hospital of Nantong University, Nantong, China.
Adv Exp Med Biol ; 1088: 3-19, 2018.
Article em En | MEDLINE | ID: mdl-30390245
Muscle is the most abundant tissue in human body, and it can be atrophy when synthesis is inferior to degradation. Muscle atrophy is prevalent as it is a complication of many diseases. Besides its devastating effects on health, it also decreases life quality and increases mortality as well. This review provides an overview of muscle atrophy, including its prevalence, economic and health burden, and clinical therapy. Its clinical therapy includes exercise training, nutritional therapy, electrical stimulation, and drugs such as testosterone and ghrelin/IGF-1 analogues. More large-scale, long-term clinical trials are needed for therapies for muscle atrophy. In addition, more therapeutic targets are highly needed.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Atrofia Muscular / Músculo Esquelético Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Atrofia Muscular / Músculo Esquelético Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article